AR039547A1 - Terapia de reemplazo hormonal - Google Patents
Terapia de reemplazo hormonalInfo
- Publication number
- AR039547A1 AR039547A1 ARP030101719A ARP030101719A AR039547A1 AR 039547 A1 AR039547 A1 AR 039547A1 AR P030101719 A ARP030101719 A AR P030101719A AR P030101719 A ARP030101719 A AR P030101719A AR 039547 A1 AR039547 A1 AR 039547A1
- Authority
- AR
- Argentina
- Prior art keywords
- days
- treatment cycle
- menopausal
- phase
- replacement therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Métodos destinados a proporcionar terapia de reemplazo hormonal a mujeres perimenopáusicas, menopáusicas y posmenopáusicas mediante la administración secuencial de combinaciones de estrógenos conjugados y trimegestona. Reivindicación 1: Un método para el tratamiento o la inhibición de trastornos menopáusicos o posmenopáusicos en una mujer perimenopáusica, menopáusica o posmenopáusica que lo necesita, que comprende proporcionar oralmente a dicha mujer, en forma continua y sin interrupciones durante 28 días en un ciclo de tratamiento de 28 días, una primera fase de una posología diaria de 0,1 a 0,45 mg de estrógenos conjugados, en la que se proporciona la misma posología de estrógenos conjugados por 10-18 días del ciclo de tratamiento, empezando el día 1 del ciclo de tratamiento y una segunda fase de una combinación de una posología diaria de 0,1 a 0,45 mg de estrógenos conjugados y 0,005 a 0,25 mg de trimegestona, en la que se proporciona la misma posología de la combinación por 10-18 días del ciclo de tratamiento, empezando el día siguiente al término de la primera fase.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38134802P | 2002-05-17 | 2002-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR039547A1 true AR039547A1 (es) | 2005-02-23 |
Family
ID=29584308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101719A AR039547A1 (es) | 2002-05-17 | 2003-05-16 | Terapia de reemplazo hormonal |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030216368A1 (es) |
| EP (1) | EP1505982A1 (es) |
| JP (1) | JP2005530790A (es) |
| CN (1) | CN1668309A (es) |
| AR (1) | AR039547A1 (es) |
| AU (1) | AU2003234574A1 (es) |
| BR (1) | BR0311184A (es) |
| CA (1) | CA2483770A1 (es) |
| MX (1) | MXPA04011257A (es) |
| TW (1) | TW200404551A (es) |
| WO (1) | WO2003097069A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060040904A1 (en) * | 2004-08-17 | 2006-02-23 | Ahmed Salah U | Vaginal cream compositions, kits thereof and methods of using thereof |
| KR101275198B1 (ko) | 2005-05-23 | 2013-06-18 | 엘지전자 주식회사 | 드럼세탁기 및 그에 적용되는 드럼 제조방법 |
| WO2007076144A2 (en) * | 2005-12-27 | 2007-07-05 | Duramed Pharmaceuticals, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| WO2007143607A2 (en) | 2006-06-02 | 2007-12-13 | Pear Tree Women's Health Care | Method of treating atrophic vaginitis |
| US20100022487A1 (en) * | 2008-07-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| US20100022494A1 (en) * | 2008-07-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| US20100022497A1 (en) * | 2008-07-24 | 2010-01-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| AU3961697A (en) * | 1996-07-26 | 1998-02-20 | American Home Products Corporation | Oral contraceptive |
| US6451778B1 (en) * | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
| AU2092300A (en) * | 1999-01-18 | 2000-08-01 | Novo Nordisk A/S | Use of estrogens and delta-gonadien-21-ol-3,20-diones in the treatment or prophylaxis of cerebral degenerative disorders |
| JP2002534469A (ja) * | 1999-01-18 | 2002-10-15 | ノボ ノルディスク アクティーゼルスカブ | エストロゲン及びデルタ−ゴナジエン−２１−オール−３，２０−ジオンの使用 |
| CA2267743C (en) * | 1999-03-30 | 2011-07-26 | Robert F. Casper | Low dose estrogen interrupted hormone replacement therapy |
| US20020107230A1 (en) * | 2000-12-22 | 2002-08-08 | Waldon R. Forrest | Methods and formulations for the treatment of female sexual dysfunction |
| WO2003028735A1 (de) * | 2001-09-29 | 2003-04-10 | Solvay Pharmaceuticals Gmbh | Estrogen-gestagen kombinationspräparat und anwendung |
-
2003
- 2003-05-13 TW TW092112924A patent/TW200404551A/zh unknown
- 2003-05-15 WO PCT/US2003/015235 patent/WO2003097069A1/en not_active Application Discontinuation
- 2003-05-15 US US10/438,643 patent/US20030216368A1/en not_active Abandoned
- 2003-05-15 MX MXPA04011257A patent/MXPA04011257A/es unknown
- 2003-05-15 JP JP2004505067A patent/JP2005530790A/ja not_active Withdrawn
- 2003-05-15 AU AU2003234574A patent/AU2003234574A1/en not_active Abandoned
- 2003-05-15 CA CA002483770A patent/CA2483770A1/en not_active Abandoned
- 2003-05-15 CN CNA038166968A patent/CN1668309A/zh active Pending
- 2003-05-15 BR BR0311184-9A patent/BR0311184A/pt not_active IP Right Cessation
- 2003-05-15 EP EP03728916A patent/EP1505982A1/en not_active Withdrawn
- 2003-05-16 AR ARP030101719A patent/AR039547A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003234574A1 (en) | 2003-12-02 |
| MXPA04011257A (es) | 2005-01-25 |
| CA2483770A1 (en) | 2003-11-27 |
| JP2005530790A (ja) | 2005-10-13 |
| TW200404551A (en) | 2004-04-01 |
| CN1668309A (zh) | 2005-09-14 |
| BR0311184A (pt) | 2005-02-22 |
| EP1505982A1 (en) | 2005-02-16 |
| US20030216368A1 (en) | 2003-11-20 |
| WO2003097069A1 (en) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200201000A1 (ru) | Гормон-заместительная терапия | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| US20060254597A1 (en) | Method of treatment of atrophic vaginitis by topical clitoral menthol or a related cooling compound | |
| ECSP088123A (es) | Anticoncepcion oral con trimegestona | |
| CO5180583A1 (es) | Administracion de esteroides androgenicos no orales a las mujeres | |
| NZ545130A (en) | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | |
| AR039546A1 (es) | Terapia de reemplazo hormonal | |
| PE20070329A1 (es) | Composiciones con estrogenos y metodos terapeuticos para su uso | |
| NZ591627A (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| AR048722A1 (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| AR039547A1 (es) | Terapia de reemplazo hormonal | |
| HUP0301791A2 (hu) | Eljárás klimaktériummal összefüggő rendellenességek kezelésére nőkben a menopauza alatt vagy után | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| HUP9901360A2 (hu) | Cimicifuga racemosa-ból származó extraktum alkalmazása | |
| AR051931A1 (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclos extendidos con dosis ascendentes | |
| AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
| MXPA02004084A (es) | Nueva composicion hormonal y su utilizacion. | |
| CR8010A (es) | Regimenes de contraceptivos transdermicos extendidos | |
| AR029189A1 (es) | Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento | |
| UY29861A1 (es) | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
| AR039227A1 (es) | Terapia de reemplazo hormonal | |
| RU2006114791A (ru) | Продленные режимы трехфазных контрацептивов | |
| BR0308968A (pt) | terapia de reposição hormonal | |
| AR049195A1 (es) | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento | |
| AR039477A1 (es) | Terapia de reemplazo hormonal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |